INSIGHTS

Research and practical buying guidance.

Browse practical buyer, technical, regulatory and evidence-led guidance across the VEMERIX knowledge library.

LATEST ARTICLES

Practical guidance from the VEMERIX team.

VEMERIX evidence review cover comparing PVA vs PU foam materials, pore mechanics, and open vs closed-incision NPWT change intervals.
Negative Pressure Wound Therapy Dressing Selection: What the PVA-versus-PU Foam, Pore-Size and Closed-Incision-versus-Open-Wound Evidence Actually SupportsNavigating NPWT dressing selection requires separating material mechanics from clinical healing claims—evaluating open-pore PU black foam (400–600 µm) for high-exudate granulation against hydro-retentive PVA white foam for sensitive wound beds, respecting the 48–72 hour open-wound change boundary, and understanding the FDA regulatory divide between open-wound (OMP) and closed-incision (QFC) devices.August 3, 2026 · 15 min read
VEMERIX report cover showing NPWT tender lot splits, FDA failure mode mapping, and supplier acceptance framework.
How to Specify a Negative Pressure Wound Therapy (NPWT) System: A Lot-by-Lot Tender, RFQ & Acceptance Checklist for Pumps, Dressings and Canisters (2026)A hospital procurement, health-system category management, or distributor team specifying negative pressure wound therapy (NPWT) should not issue a single bundled RFQ. Structure tenders into platform lots (acute heavy-duty, portable ambulatory, single-use/disposable, consumables, rental), map every pump performance and alarm requirement directly to documented FDA failure modes (leak, occlusion, canister overflow, power thermal cutoff), and demand a 6-part regulatory evidence pack (510(k), UDI, ISO 10993, IEC 60601-1, EO sterilization) before awarding volume.August 3, 2026 · 18 min read
An on-brand VEMERIX report cover: a single dressing shown as a ladder of regulatory classes, rendered in accent-pink linework on a clean off-white field.
The Line That Decides the Class: How a Wound Dressing's Claim — Not Its Chemistry — Sets Its Regulatory Class in the US, EU and ChinaIn wound and skin care the label claim, not the material, sets the regulatory class — and because most of the category is 510(k)-exempt in the United States, the public clearance record systematically under-describes who actually supplies it. A primary-source read of 31 FDA product codes, EU MDR Rule 4 and NMPA's 2022 catalogue change.July 27, 2026 · 27 min read
An on-brand VEMERIX report cover: four minimally-invasive device lines converging on a single registered single-use consumable, rendered as a minimal razor-and-blade motif in accent-pink linework on a clean off-white field.
The Single-Use Turn: Why Four Minimally-Invasive Device Lines Are All Migrating From the Durable Machine to the Registered Consumable — and What It Means for How You SourceAcross four unrelated device lines — vein ablation, wound therapy, circumcision, aesthetic injection — the same shift recurs: the durable machine commoditizes and value migrates to the registered single-use consumable. One pattern, three economic engines, and one sourcing conclusion: buy the platform, not the SKU.July 20, 2026 · 21 min read